MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

Search

Tandem Diabetes Care Inc

Geschlossen

BrancheGesundheitswesen

17.18 -7.83

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.91

Max

18.65

Schlüsselkennzahlen

By Trading Economics

Einkommen

-131M

-131M

Verkäufe

-48M

234M

EPS

-0.665

Gewinnspanne

-55.693

Angestellte

2,650

EBITDA

-121M

-116M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+102.74% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

79M

1.2B

Vorheriger Eröffnungskurs

25.01

Vorheriger Schlusskurs

17.18

Nachrichtenstimmung

By Acuity

50%

50%

163 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Tandem Diabetes Care Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Juli 2025, 23:09 UTC

Ergebnisse

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1. Juli 2025, 19:16 UTC

Akquisitionen, Fusionen, Übernahmen

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1. Juli 2025, 23:47 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1. Juli 2025, 23:41 UTC

Market Talk

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1. Juli 2025, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie: Deal Represents Implied Value of $8.4 Billion

1. Juli 2025, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1. Juli 2025, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie Completes Acquisition of AZEK

1. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. Juli 2025, 20:24 UTC

Ergebnisse

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1. Juli 2025, 19:55 UTC

Market Talk

Oil Futures Resume Cautious Rally -- Market Talk

1. Juli 2025, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1. Juli 2025, 19:12 UTC

Market Talk

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1. Juli 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1. Juli 2025, 18:41 UTC

Akquisitionen, Fusionen, Übernahmen

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1. Juli 2025, 18:33 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

1. Juli 2025, 18:33 UTC

Market Talk

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1. Juli 2025, 18:32 UTC

Market Talk

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1. Juli 2025, 18:22 UTC

Market Talk

Remittances to Mexico Down in May -- Market Talk

1. Juli 2025, 17:45 UTC

Market Talk

Seasonal Demand Supports Further Oil Gains -- Market Talk

1. Juli 2025, 17:01 UTC

Akquisitionen, Fusionen, Übernahmen

Danone Completed Acquisition of Majority Stake in Kate Farms

1. Juli 2025, 16:55 UTC

Ergebnisse

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1. Juli 2025, 16:27 UTC

Market Talk

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1. Juli 2025, 16:25 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juli 2025, 15:48 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1. Juli 2025, 15:46 UTC

Market Talk

Global Equities Roundup: Market Talk

1. Juli 2025, 15:46 UTC

Market Talk

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1. Juli 2025, 14:54 UTC

Market Talk

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1. Juli 2025, 14:49 UTC

Market Talk

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Peer-Vergleich

Kursveränderung

Tandem Diabetes Care Inc Prognose

Kursziel

By TipRanks

102.74% Vorteil

12-Monats-Prognose

Durchschnitt 37.79 USD  102.74%

Hoch 75 USD

Tief 18 USD

Basierend auf 16 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tandem Diabetes Care Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

16 ratings

9

Buy

6

Halten

1

Sell

Technischer Score

By Trading Central

21.29 / N/AUnterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

163 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.